Financial Information of Anthem Biosciences Limited IPO
The Revenues from operations for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 19,302.85 Million, ₹ 14,830.69 Million and ₹ 11,339.92 Million. The EBITDA for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 7,565.68 Million, ₹ 5,686.77 Million and ₹ 5,677.56 Million. The Profit after Tax for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 4,512.59 Million, ₹ 3,673.10 Million and ₹ 3,581.85 Million respectively. This indicates a steady growth in financial performance.
| Period Ended | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|
| Reserve of Surplus | 22,980.49 | 18,128.39 | 16,265.71 |
| Total Assets | 28,075.83 | 23,981.14 | 20,144.58 |
| Total Borrowings | 1,089.54 | 2,325.25 | 1,250.64 |
| Fixed Assets | 6,964.42 | 4,699.86 | 4,384.65 |
| Cash | 3,161.42 | 1,838.60 | 3,422.36 |
| Net Borrowing | -2,071.88 | 486.65 | -2,171.72 |
| Revenue | 19,302.85 | 14,830.69 | 11,339.92 |
| EBITDA | 7,565.68 | 5,686.77 | 5,677.56 |
| PAT | 4,512.59 | 3,673.10 | 3,851.85 |
| EPS | 8.07 | 6.48 | 6.75 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Offer, given in FINANCIAL EXPRESS.
Option Trading with CA Abhay
Stock Market Masterclass
Option Trading with CA Abhay
Stock Market Masterclass
Copyright @2020 Design & Developed by Info Web Software